How Old Blood Cells Become Young Neural Stem Cells

At first glance, the result sounds like a biological time machine. Researchers took blood-derived cells from donors ranging from newborns to 101 years old and converted them into neural stem cells whose molecular age looked dramatically younger. The surprising part, though, was not only how young the cells became. It was how long the change continued after the cells had already started looking neural.

The study, published in Aging Cell on October 3, 2026, helps explain what happens inside a cell during direct reprogramming. It also puts a necessary boundary around the headline: an 80-year-old person was not made young. Cells grown in a laboratory changed their identity and lost many age-associated molecular marks.

Molecular age is not the same as calendar age

The key idea is epigenetics, the layer of chemical instructions that helps control which genes a cell uses without changing the DNA sequence itself. One important epigenetic mark is DNA methylation, in which small chemical groups attach to particular places on DNA and influence gene activity.

As people age, DNA methylation patterns tend to change in predictable ways. Researchers can measure those patterns and feed them into an epigenetic clock, a statistical algorithm that estimates a cell’s molecular age. It is useful, but it is not a complete health report. A clock reading does not mean that every aspect of aging has been reversed.

In this study, the converted cells retained about 13% of their donor’s chronological age at low passage and about 5% after further expansion. A passage is one round of growing cells and transferring them into fresh culture. To see the arithmetic behind the headline:

80 years × 0.13 ≈ 10.4 clock-years
80 years × 0.05 ≈ 4 clock-years

Those figures are rough illustrations based on group-level results, not an exact reading for every cell from an 80-year-old donor. Still, they explain how a molecular age below 20 can appear in a laboratory culture without claiming that the donor’s body has been rejuvenated.

The starting material was not a mature red blood cell

The researchers began with erythroid progenitor cells, immature blood cells on the pathway toward becoming red blood cells. These cells came from peripheral blood and were more flexible than fully mature blood cells, giving the researchers a workable starting population.

They then used a Sendai virus-based delivery system to temporarily provide instructions for two transcription factors, proteins that switch groups of genes on or off: SOX2 and cMYC. Rather than pushing the cells through a fully pluripotent state, the team used a direct route into the neural lineage.

A pluripotent cell is a cell that can develop into many different body-cell types. Induced pluripotent stem cells, often called iPSCs, are made by resetting mature cells into that flexible state. The Bonn and Aachen researchers instead produced induced neural stem cells, or iNSCs, which are self-renewing cells prepared for neural development.

That shortcut matters. It avoids one major stage of conventional reprogramming, but it does not mean the conversion happens in a single dramatic jump. Neural markers began appearing within roughly two weeks. PAX6, a protein used as an early neural stem-cell marker, could be detected around day 12. Yet the cells were still consolidating their new identity long afterward.

A cell can look new before it is fully rewritten

To follow that transition, the researchers collected cells at several points during conversion. They measured DNA methylation and used RNA sequencing, a method for reading which genes are active, to track both molecular age and cell identity.

The timeline was slower than expected. Most age-associated DNA methylation signatures were reset over roughly 50 days. Differences between young-donor and old-donor cells also faded as conversion continued. Meanwhile, the full gene signature of a genuine neural stem cell extended beyond the point when proliferating, PAX6-positive cells first appeared.

That distinction is easy to miss. A visible marker can announce that a cell has started a new job, but it does not prove that the cell has completely settled into that job. The researchers’ results suggest that direct conversion is less like flipping a switch and more like learning a new language: the accent changes early, while fluency takes longer.

The age reset did not depend only on cell division

One possible explanation was that rapidly dividing cells might dilute their old molecular marks as they multiplied. To test that idea, the team slowed cell proliferation, meaning cell growth and division, with laboratory treatments that reduced the number of times the cells doubled.

The cells divided less, but epigenetic de-aging continued. That result suggests the age reset is not merely a consequence of cell division. The cells appear to be actively reorganizing their gene-control system as they change fate, although this experiment does not identify every molecular mechanism involved.

The established iNSC lines from older donors also lacked many of the age-associated features examined by the researchers. Measures related to cellular senescence, a state in which stressed cells stop dividing, along with autophagy, DNA damage, and mitochondrial reactive oxygen species did not show the expected old-cell pattern. In several respects, the lines resembled neural stem cells produced through conventional iPSC methods.

Why this matters beyond a striking headline

The immediate value of the work is as a research model. Scientists now have a longer time window in which to separate two processes that often get mixed together: changing what a cell is and changing how old it appears molecularly. That could help reveal which gene-control systems drive cellular de-aging.

The finding may also matter for disease modeling. Cells from older patients carry age-related features that can be valuable when studying late-onset neurological disorders. Direct conversion may preserve some disease-causing information while erasing other age signals, so researchers will need to understand exactly what disappears and what remains.

This is not yet a rejuvenation treatment. The experiments were performed on cultured cells, and any future therapeutic use would require careful testing for genetic stability, cell purity, immune compatibility, and unwanted growth. The study’s real achievement is more precise and more useful than a promise of human age reversal: it shows that a blood cell can acquire a neural stem-cell identity while its molecular age keeps unwinding for weeks.

The result is not a time machine. It is a slow, measurable change of cellular state, and that slower timeline may be the most valuable discovery of all.